Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola Glycoprotein

Survival following Ebola virus (EBOV) infection correlates with the ability to mount an early and robust interferon (IFN) response. The host IFN-induced proteins that contribute to controlling EBOV replication are not fully known. Among the top genes with the strongest early increases in expression...

Full description

Bibliographic Details
Main Authors: Ermela Paparisto, Nina R. Hunt, Daniel S. Labach, Macon D. Coleman, Eric J. Di Gravio, Mackenzie J. Dodge, Nicole J. Friesen, Marceline Côté, Andreas Müller, Thomas Hoenen, Stephen D. Barr
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/9/2399
_version_ 1797519814789431296
author Ermela Paparisto
Nina R. Hunt
Daniel S. Labach
Macon D. Coleman
Eric J. Di Gravio
Mackenzie J. Dodge
Nicole J. Friesen
Marceline Côté
Andreas Müller
Thomas Hoenen
Stephen D. Barr
author_facet Ermela Paparisto
Nina R. Hunt
Daniel S. Labach
Macon D. Coleman
Eric J. Di Gravio
Mackenzie J. Dodge
Nicole J. Friesen
Marceline Côté
Andreas Müller
Thomas Hoenen
Stephen D. Barr
author_sort Ermela Paparisto
collection DOAJ
description Survival following Ebola virus (EBOV) infection correlates with the ability to mount an early and robust interferon (IFN) response. The host IFN-induced proteins that contribute to controlling EBOV replication are not fully known. Among the top genes with the strongest early increases in expression after infection in vivo is IFN-induced HERC5. Using a transcription- and replication-competent VLP system, we showed that HERC5 inhibits EBOV virus-like particle (VLP) replication by depleting EBOV mRNAs. The HERC5 RCC1-like domain was necessary and sufficient for this inhibition and did not require zinc finger antiviral protein (ZAP). Moreover, we showed that EBOV (Zaire) glycoprotein (GP) but not Marburg virus GP antagonized HERC5 early during infection. Our data identify a novel ‘protagonist–antagonistic’ relationship between HERC5 and GP in the early stages of EBOV infection that could be exploited for the development of novel antiviral therapeutics.
first_indexed 2024-03-10T07:49:04Z
format Article
id doaj.art-297711648a4f49ebb60f09d6ccd3db49
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T07:49:04Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-297711648a4f49ebb60f09d6ccd3db492023-11-22T12:25:33ZengMDPI AGCells2073-44092021-09-01109239910.3390/cells10092399Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola GlycoproteinErmela Paparisto0Nina R. Hunt1Daniel S. Labach2Macon D. Coleman3Eric J. Di Gravio4Mackenzie J. Dodge5Nicole J. Friesen6Marceline Côté7Andreas Müller8Thomas Hoenen9Stephen D. Barr10Department of Microbiology and Immunology, Schulich School of Medicine and Dentistry, Western University, Dental Sciences Building Room 3007, London, ON N6A 5C1, CanadaDepartment of Microbiology and Immunology, Schulich School of Medicine and Dentistry, Western University, Dental Sciences Building Room 3007, London, ON N6A 5C1, CanadaDepartment of Microbiology and Immunology, Schulich School of Medicine and Dentistry, Western University, Dental Sciences Building Room 3007, London, ON N6A 5C1, CanadaDepartment of Microbiology and Immunology, Schulich School of Medicine and Dentistry, Western University, Dental Sciences Building Room 3007, London, ON N6A 5C1, CanadaDepartment of Microbiology and Immunology, Schulich School of Medicine and Dentistry, Western University, Dental Sciences Building Room 3007, London, ON N6A 5C1, CanadaDepartment of Microbiology and Immunology, Schulich School of Medicine and Dentistry, Western University, Dental Sciences Building Room 3007, London, ON N6A 5C1, CanadaDepartment of Microbiology and Immunology, Schulich School of Medicine and Dentistry, Western University, Dental Sciences Building Room 3007, London, ON N6A 5C1, CanadaDepartment of Biochemistry, Microbiology, and Immunology, Ottawa Institute of Systems Biology, University of Ottawa, Roger-Guindon Hall Room 4214, Ottawa, ON K1H 8M5 , CanadaFriedrich-Loeffler-Institut, Institute of Molecular Virology and Cell Biology, Südufer 10, 17493 Greifswald—Insel Riems, GermanyFriedrich-Loeffler-Institut, Institute of Molecular Virology and Cell Biology, Südufer 10, 17493 Greifswald—Insel Riems, GermanyDepartment of Microbiology and Immunology, Schulich School of Medicine and Dentistry, Western University, Dental Sciences Building Room 3007, London, ON N6A 5C1, CanadaSurvival following Ebola virus (EBOV) infection correlates with the ability to mount an early and robust interferon (IFN) response. The host IFN-induced proteins that contribute to controlling EBOV replication are not fully known. Among the top genes with the strongest early increases in expression after infection in vivo is IFN-induced HERC5. Using a transcription- and replication-competent VLP system, we showed that HERC5 inhibits EBOV virus-like particle (VLP) replication by depleting EBOV mRNAs. The HERC5 RCC1-like domain was necessary and sufficient for this inhibition and did not require zinc finger antiviral protein (ZAP). Moreover, we showed that EBOV (Zaire) glycoprotein (GP) but not Marburg virus GP antagonized HERC5 early during infection. Our data identify a novel ‘protagonist–antagonistic’ relationship between HERC5 and GP in the early stages of EBOV infection that could be exploited for the development of novel antiviral therapeutics.https://www.mdpi.com/2073-4409/10/9/2399Ebola virusMarburg virusHERC5antiviralinterferon
spellingShingle Ermela Paparisto
Nina R. Hunt
Daniel S. Labach
Macon D. Coleman
Eric J. Di Gravio
Mackenzie J. Dodge
Nicole J. Friesen
Marceline Côté
Andreas Müller
Thomas Hoenen
Stephen D. Barr
Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola Glycoprotein
Cells
Ebola virus
Marburg virus
HERC5
antiviral
interferon
title Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola Glycoprotein
title_full Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola Glycoprotein
title_fullStr Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola Glycoprotein
title_full_unstemmed Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola Glycoprotein
title_short Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola Glycoprotein
title_sort interferon induced herc5 inhibits ebola virus particle production and is antagonized by ebola glycoprotein
topic Ebola virus
Marburg virus
HERC5
antiviral
interferon
url https://www.mdpi.com/2073-4409/10/9/2399
work_keys_str_mv AT ermelapaparisto interferoninducedherc5inhibitsebolavirusparticleproductionandisantagonizedbyebolaglycoprotein
AT ninarhunt interferoninducedherc5inhibitsebolavirusparticleproductionandisantagonizedbyebolaglycoprotein
AT danielslabach interferoninducedherc5inhibitsebolavirusparticleproductionandisantagonizedbyebolaglycoprotein
AT macondcoleman interferoninducedherc5inhibitsebolavirusparticleproductionandisantagonizedbyebolaglycoprotein
AT ericjdigravio interferoninducedherc5inhibitsebolavirusparticleproductionandisantagonizedbyebolaglycoprotein
AT mackenziejdodge interferoninducedherc5inhibitsebolavirusparticleproductionandisantagonizedbyebolaglycoprotein
AT nicolejfriesen interferoninducedherc5inhibitsebolavirusparticleproductionandisantagonizedbyebolaglycoprotein
AT marcelinecote interferoninducedherc5inhibitsebolavirusparticleproductionandisantagonizedbyebolaglycoprotein
AT andreasmuller interferoninducedherc5inhibitsebolavirusparticleproductionandisantagonizedbyebolaglycoprotein
AT thomashoenen interferoninducedherc5inhibitsebolavirusparticleproductionandisantagonizedbyebolaglycoprotein
AT stephendbarr interferoninducedherc5inhibitsebolavirusparticleproductionandisantagonizedbyebolaglycoprotein